文献速递关节外科

无菌性翻修全膝关节置换术后再入院成本趋势的特征分析

Characterizing the Cost Trends of Readmissions After Aseptic Revision Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-03-21

基于2009年1月1日至2022年6月30日全国大型数据库的回顾性分析,34,144例无菌性翻修全膝关节置换患者中1,953例(5.7%)在术后90天内再入院,再入院中位成本为25,181美元,需再次手术者成本更高,假体周围感染是外科并发症中最常见且成本最高的原因。

要点

  • 无菌性翻修全膝关节置换术后90天再入院率为5.7%(1,953/34,144),其中医疗原因占56.1%、外科原因占29.2%、未知占14.8%。
  • 所有再入院的中位成本为25,181美元,需再次手术的再入院中位成本为40,524美元,高于无需再次手术的20,907美元(P < 0.001)。
  • 外科并发症再入院中假体周围感染最常见(36.3%)且成本最高(中位38,104美元),医疗原因再入院最常见为康复治疗、缺血性心脏事件和急性肾损伤。

核心结论

  • 无菌性翻修全膝关节置换术后再入院给医疗系统带来重大经济负担,尤其是涉及外科并发症和需要再次手术的再入院。
  • 本研究强调需要有针对性的策略以有效降低翻修全膝关节置换术后再入院的发生率和成本,目标是控制成本和改善患者结局。

研究设计与样本

  • 回顾性分析,使用2009年1月1日至2022年6月30日的大型全国数据库数据。
  • 通过现行操作术语代码识别接受无菌性翻修全膝关节置换的患者,分析术后90天内再入院情况,比较基线特征、合并症和再入院成本,并识别再入院的显著危险因素。
  • 共纳入34,144例无菌性翻修全膝关节置换患者,其中1,953例(5.7%)在术后90天内再入院。

主要发现

  • 再入院原因构成:医疗原因占56.1%,外科原因占29.2%,未知占14.8%。
  • 所有再入院的中位成本为25,181美元;需要再次手术的再入院中位成本为40,524美元,高于不需要再次手术的20,907美元(P < 0.001)。
  • 外科并发症再入院中,假体周围感染最常见(36.3%),且与最高成本相关(中位38,104美元)。
  • 医疗原因再入院中最常见的是康复治疗、缺血性心脏事件和急性肾损伤。
  • 全因再入院的显著危险因素包括男性、因假体周围骨折行指数翻修,以及合并症包括糖尿病、冠状动脉疾病、肾脏疾病和充血性心力衰竭。

关键数值与推荐

  • 无菌性翻修全膝关节置换术后90天再入院率为5.7%(1,953/34,144)。
  • 再入院中位成本:所有再入院25,181美元;需再次手术者40,524美元 vs 不需再次手术者20,907美元(P < 0.001)。
  • 假体周围感染占外科并发症再入院的36.3%,其中位成本为38,104美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A rise in total knee arthroplasty (TKA) volume has led to an increased incidence of aseptic revision TKA (rTKA), resulting in major associated health care costs. This study evaluated the economic impact and clinical factors associated with readmission following aseptic rTKA, aiming to identify key drivers of cost and risk factors for readmission. METHODS: This retrospective analysis used data from a large national database from January 1, 2009, to June 30, 2022. Patients undergoing aseptic rTKA were identified via Current Procedural Terminology codes. Readmissions within 90 days postoperatively were analyzed. Baseline characteristics, comorbidities, and readmission costs were compared, and significant risk factors for readmission were identified. Of 34,144 aseptic rTKA patients, 1,953 (5.7%) were readmitted within 90 days (56.1% medical, 29.2% surgical, and 14.8% unknown). RESULTS: The median cost of all readmissions was $25,181. Readmissions requiring reoperation had a higher cost (median $40,524 versus $20,907, P < 0.001). Among readmissions for surgical complications, periprosthetic joint infection was the most common cause (36.3%) and was associated with the greatest cost (median $38,104). The most common medical causes of readmission were rehabilitative care, ischemic cardiac events, and acute kidney injury. Significant risk factors for all-cause readmission included men, index revision for periprosthetic fracture, and comorbidities, including diabetes, coronary artery disease, renal disease, and congestive heart failure. CONCLUSIONS: Readmission after aseptic rTKA results in a major economic burden to the health care system, particularly in readmission pertaining to surgical complications and requiring reoperation. This study highlights the need for targeted strategies aimed at effectively reducing the rate and costs associated with readmission post-rTKA with a goal of cost containment and improved patient outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hrudka BT, Fuqua AA, Nguyen J, et al. Characterizing the Cost Trends of Readmissions After Aseptic Revision Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40122219. doi:10.1016/j.arth.2025.03.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。